当前位置: X-MOL 学术Ann. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment
Annals of Oncology ( IF 56.7 ) Pub Date : 2017-06-23 , DOI: 10.1093/annonc/mdx317
P. Holch , L. Warrington , L.C.A. Bamforth , A. Keding , L.E. Ziegler , K. Absolom , C. Hector , C. Harley , O. Johnson , G. Hall , C. Morris , G. Velikova

Significant adverse events (AE) during cancer therapy disrupt treatment and escalate to emergency admissions. Approaches to improve the timeliness and accuracy of AE reporting may improve safety and reduce health service costs. Reporting AE via patient reported outcomes (PROs), can improve clinician–patient communication and making data available to clinicians in ‘real-time’ using electronic PROs (ePROs) could potentially transform clinical practice by providing easily accessible records to guide treatment decisions. This manuscript describes the development of eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) is a National Institute for Health Research-funded programme, a system for patients to self-report and manage AE online during and after cancer treatment.

中文翻译:

开发用于患者自我报告和管理癌症治疗过程中不良事件的集成电子平台

癌症治疗期间的重大不良事件(AE)会中断治疗并升级为紧急情况。改善AE报告及时性和准确性的方法可以提高安全性并降低卫生服务成本。通过患者报告的结局(PRO)报告不良事件,可以改善临床医生与患者之间的沟通,并通过使用电子PRO(ePRO)实时向临床医生提供数据,可以通过提供易于访问的记录来指导治疗决策,从而潜在地改变临床实践。该手稿描述了eRAPID(不良事件的电子患者自我报告:患者信息和咨询)的开发,它是由美国国立卫生研究院资助的计划,该系统可让患者在癌症发生期间及之后进行自我报告和在线管理AE治疗。
更新日期:2017-09-18
down
wechat
bug